Shun Lü

机构：Shanghai Jiao Tong University, Shanghai Chest Hospital, Shanghai Cancer Institute, Huashan Hospital · ORCID：0000-0001-8833-7262

发表论文 915 篇 · 总被引 39163 次 · h-index 79

代表论文

• Author Correction: A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice (2026 · Nature Microbiology · 被引 1)
• Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial (2026 · The Lancet Oncology · 被引 1)
• Supplementary Data 1 from Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer (2026)
• Data from Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer (2026)
• SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial (2026 · Cancer Cell)
• Real-world treatment pattern and clinical outcomes in Chinese NSCLC patients with KRAS G12C mutation (2026 · BMC Cancer)